<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR522.html">Part 522
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 522.1660  Oxytetracycline injectable dosage forms.   Sec. 522.1660a  Oxytetracycline solution, 200 milligrams/milliliter.
                            </h3>
                            <p class="depth1"><em>(a)</em> Specifications. Each milliliter of sterile solution contains 200  milligrams of oxytetracycline base.</p><p class="depth1"><em>(b)</em> Sponsors. See Nos. 000010, 000859, 048164, 054771, 055529,  057561, and 061623 in Sec. 510.600(c) of this chapter.</p><p class="depth1"><em>(c)</em> Related tolerances. See Sec. 556.500 of this chapter.</p><p class="depth1"><em>(d)</em> Special considerations. When labeled for the treatment of  anaplasmosis or anthrax, labeling shall also bear the following:  ``Federal law restricts this drug to use by or on the order of a  licensed veterinarian.''</p><p class="depth1"><em>(e)</em> Conditions of use--</p><p class="depth2"><em>(1)</em> Beef cattle, dairy cattle, and calves  including prerumenative (veal) calves--</p><p class="depth3"><em>(i)</em> Amounts and indications for  use--</p><p class="depth4"><em>(A)</em> 3 to 5 mg per pound of body weight (mg/lb BW) per day (/day)  intramuscularly, subcutaneously, or intravenously for treatment of  pneumonia and shipping fever complex associated with Pasteurella spp.  and Haemophilus spp., foot-rot and diphtheria caused by Fusobacterium  necrophorum, bacterial enteritis (scours) caused by Escherichia coli,  wooden tongue caused by Actinobacillus lignieresii, leptospirosis caused  by Leptospira pomona, wound infections and acute metritis caused by  Staphylococcus spp. and Streptococcus spp., and anthrax caused by  Bacillus anthracis.</p><p class="depth4"><em>(B)</em> 5 mg/lb BW/day intramuscularly or intravenously for treatment of  anaplasmosis caused by Anaplasma marginale, severe foot-rot, and  advanced cases of other indicated diseases.</p><p class="depth4"><em>(C)</em> 9 mg/lb BW intramuscularly or subcutaneously as single dosage  where retreatment of calves and yearlings for bacterial pneumonia is  impractical, for treatment of infectious bovine keratoconjunctivitis  (pinkeye) caused by Moraxella bovis, or where retreatment for  anaplasmosis is impractical.</p><p class="depth3"><em>(ii)</em> Limitations. Exceeding the highest recommended level of drug  per pound of bodyweight per day, administering more than the recommended  number of treatments, and/or exceeding 10 mL intramuscularly or  subcutaneously per injection site may result in antibiotic residues  beyond the withdrawal time. Rapid intravenous administration in cattle  may result in animal collapse. Oxytetracycline should be administered  intravenously slowly over a period of at least 5 minutes. Discontinue  treatment at least 28 days prior to slaughter. Milk taken from animals  during treatment and for 96 hours after the last treatment must not be  used for food.</p><p class="depth2"><em>(2)</em> Swine--</p><p class="depth3"><em>(i)</em> Amounts and indications for use--</p><p class="depth4"><em>(A)</em> Sows: 3 mg/lb BW  intramuscularly once, approximately 8 hours before farrowing or  immediately after completion of farrowing, as an aid in control of  infectious enteritis (baby pig scours, colibacillosis) in suckling pigs  caused by E. coli.</p><p class="depth4"><em>(B)</em> 3 to 5 mg/lb BW/day intramuscularly for treatment of bacterial  enteritis (scours, colibacillosis) caused by E. coli, pneumonia caused  by Pasteurella multocida, and leptospirosis caused by Leptospira pomona.</p><p class="depth4"><em>(C)</em> 9 mg/lb BW as a single dosage where retreatment for pneumonia is  impractical.</p><p class="depth3"><em>(ii)</em> Limitations. Administer intramuscularly. Do not inject more   than 5 mL per site in adult swine. Discontinue treatment at least 28  days prior to slaughter.  [45 FR 16479, Mar. 14, 1980. Redesignated and amended at 69 FR 31879,  June 8, 2004]</p><p class="depth0">Editorial Note: For Federal Register citations affecting Sec.  522.1660a, see the List of CFR Sections Affected, which appears in the  Finding Aids section of the printed volume and at www.fdsys.gov.    Sec. 522.1660b  Oxytetracycline solution, 300 milligrams/milliliter.</p><p class="depth1"><em>(a)</em> Specifications. Each milliliter (mL) of solution contains 300  milligrams (mg) oxytetracycline base.</p><p class="depth1"><em>(b)</em> Sponsor. See No. 055529 in Sec. 510.600(c) of this chapter.</p><p class="depth1"><em>(c)</em> Related tolerances. See Sec. 556.500 of this chapter.</p><p class="depth1"><em>(d)</em> Special considerations. When labeled for use as in paragraph  (e)(1)(i)(D) or (e)(1)(i)(E) of this section, labeling shall also bear  the following: ``Federal law restricts this drug to use by or on the  order of a licensed veterinarian.''.</p><p class="depth1"><em>(e)</em> Conditions of use--</p><p class="depth2"><em>(1)</em> Beef cattle, nonlactating dairy cattle,  and calves including preruminating (veal) calves--</p><p class="depth3"><em>(i)</em> Amounts and  indications for use--</p><p class="depth4"><em>(A)</em> 3 to 5 mg per pound of bodyweight (mg/lb BW)  per day (/day) intramuscularly, subcutaneously, or intravenously for  treatment of pneumonia and shipping fever complex associated with  Pasteurella spp. and Histophilus spp., foot-rot and diphtheria caused by  Fusobacterium necrophorum, bacterial enteritis (scours) caused by  Escherichia coli, wooden tongue caused by Actinobacillus lignieresii,  leptospirosis caused by Leptospira pomona, wound infections and acute  metritis caused by Staphylococcus spp. and Streptococcus spp.</p><p class="depth4"><em>(B)</em> 5 mg/lb BW/day intramuscularly, subcutaneously, or intravenously  for treatment of severe foot-rot, and advanced cases of other indicated  diseases.</p><p class="depth4"><em>(C)</em> 9 mg/lb BW intramuscularly or subcutaneously as single dosage  where retreatment of calves and yearlings for bacterial pneumonia is  impractical or for treatment of infectious bovine keratoconjunctivitis  (pinkeye) caused by Moraxella bovis.</p><p class="depth4"><em>(D)</em> 9 to 13.6 mg/lb BW intramuscularly or subcutaneously as single  dosage where retreatment of calves and yearlings for bacterial pneumonia  is impractical or for treatment of infectious bovine  keratoconjunctivitis (pinkeye) caused by Moraxella bovis.</p><p class="depth4"><em>(E)</em> 13.6 mg/lb BW intramuscularly or subcutaneously as a single  dosage for control of respiratory disease in cattle at high risk of  developing BRD associated with Mannheimia (Pasteurella) haemolytica.</p><p class="depth3"><em>(ii)</em> Limitations. Treatment should be continued 24 to 48 hours  following remission of disease signs, however, not to exceed a total of  four consecutive days. Do not inject more than 10 mL per site in adult  cattle, reducing the volume according to age and body size to 1 to 2 mL  in small calves. Exceeding the highest recommended level of drug/lb BW/ day, administering more than the recommended number of treatments, and/ or exceeding 10 mL intramuscularly or subcutaneously per injection site  may result in antibiotic residues beyond the withdrawal time. Rapid  intravenous administration may result in animal collapse.  Oxytetracycline should be administered intravenously slowly over a  period of at least 5 minutes. Discontinue treatment at least 28 days  prior to slaughter. Not for use in lactating dairy animals.</p><p class="depth2"><em>(2)</em> Swine--</p><p class="depth3"><em>(i)</em> Amounts and indications for use--</p><p class="depth4"><em>(A)</em> Sows: 3 mg/lb BW  intramuscularly once, approximately 8 hours before farrowing or  immediately after completion of farrowing, as an aid in control of  infectious enteritis (baby pig scours, colibacillosis) in suckling pigs  caused by E. coli.</p><p class="depth4"><em>(B)</em> 3 to 5 mg/lb BW/day intramuscularly for treatment of bacterial  enteritis (scours, colibacillosis) caused by E. coli, pneumonia caused  by Pasteurella multocida, and leptospirosis caused by Leptospira pomona.</p><p class="depth4"><em>(C)</em> 9 mg/lb BW as a single dosage where retreatment for pneumonia is  impractical.</p><p class="depth3"><em>(ii)</em> Limitations. Administer intramuscularly. Treatment should be  continued 24 to 48 hours beyond remission of disease signs, however, not  to exceed a total of 4 consecutive days. Exceeding the highest  recommended level of drug/lb BW/day, administering more than the  recommended number of   treatments, and/or exceeding 5 mL intramuscularly per injection site may  result in antibiotic residues beyond the withdrawal time. Discontinue  treatment at least 28 days prior to slaughter.  [68 FR 54805, Sept. 19, 2003. Redesignated and amended at 69 FR 31879,  June 8, 2004; 73 FR 14926, Mar. 20, 2008]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
